NORGES BANK - ANACOR PHARMACEUTICALS INC ownership

ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 4 filers reported holding ANACOR PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORGES BANK ownership history of ANACOR PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$17,793,000
-55.2%
332,886
-5.4%
0.01%
-55.0%
Q4 2015$39,759,000
+102.1%
351,941
+110.6%
0.02%
+100.0%
Q3 2015$19,669,000
+717.2%
167,093
+301.5%
0.01%
+900.0%
Q1 2015$2,407,000
+79.4%
41,6150.0%0.00%0.0%
Q4 2014$1,342,00041,6150.00%
Other shareholders
ANACOR PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 1,067,892$61,778,00025.76%
VHCP Management, LLC 1,178,474$68,175,00015.70%
Palo Alto Investors LP 3,259,045$188,536,0009.32%
HWG Holdings LP 69,898$4,044,0006.53%
Consonance Capital Management LP 830,151$48,024,0004.37%
EMORY UNIVERSITY 23,325$1,349,0002.55%
Baker Brothers Advisors 4,204,702$243,242,0002.02%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 117,875$6,819,0001.55%
KINGDON CAPITAL MANAGEMENT, L.L.C. 595,300$34,438,0001.46%
Century Capital Management, LLC 1,030,483$45,609,0001.31%
View complete list of ANACOR PHARMACEUTICALS INC shareholders